Form 4: X4 Pharmaceuticals CFO Sells Shares
Insider Transaction (Form 4)
David Kirske, Chief Financial Officer of X4 Pharmaceuticals, Inc, sold 11,767 shares of common stock on October 1, 2026 for $2.86 per share.
Summary
- Open-market sale: disposed of 11,767 Common Stock at $2.86 ($33,658) on October 1, 2026; holds 155,983 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative signal: an insider sold $33,658 of stock on the open market.
Insider Transactions
David Kirske — Officer (Chief Financial Officer)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-10-01 | Open-market sale | Common Stock | 11,767 | $3 | $33.7K | 155,983 |
Key Dates
| Date | Description |
|---|---|
| 2026-10-01 | Open-market sale (11,767 shares) |
Keywords
insider transaction, Form 4, XFOR, X4 Pharmaceuticals, Inc, bearish, David Kirske
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.